In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European re...

por Trew, Geoffrey H, Brown, Adam P, Gillard, Samantha, Blackmore, Stuart, Clewlow, Christine, O'Donohoe, Paul, Wasiak, Radoslaw
Publicado 2010

Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte

por Abbara, Ali, Vuong, Lan N., Ho, Vu N. A., Clarke, Sophie A., Jeffers, Lisa, Comninos, Alexander N., Salim, Rehan, Ho, Tuong M., Kelsey, Tom W., Trew, Geoffrey H., Humaidan, Peter, Dhillo, Waljit S.
Publicado 2018

FSH Requirements for Follicle Growth During Controlled Ovarian Stimulation

por Abbara, Ali, Patel, Aaran, Hunjan, Tia, Clarke, Sophie A., Chia, Germaine, Eng, Pei Chia, Phylactou, Maria, Comninos, Alexander N., Lavery, Stuart, Trew, Geoffrey H., Salim, Rehan, Rai, Raj S., Kelsey, Tom W., Dhillo, Waljit S.
Publicado 2019

A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of Actamax™ Adhesion Barrier

por Trew, Geoffrey H., Pistofidis, George A., Brucker, Sara Y., Krämer, Bernhard, Ziegler, Nicole M., Korell, Matthias, Ritter, Henning, McConnachie, Alex, Ford, Ian, Crowe, Alison M., Estridge, Trudy D., Diamond, Michael P., De Wilde, Rudy L.
Publicado 2016

Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment

por Abbara, Ali, Hunjan, Tia, Ho, Vu N. A., Clarke, Sophie A., Comninos, Alexander N., Izzi-Engbeaya, Chioma, Ho, Tuong M., Trew, Geoffrey H., Hramyka, Artsiom, Kelsey, Tom, Salim, Rehan, Humaidan, Peter, Vuong, Lan N., Dhillo, Waljit S.
Publicado 2020

Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome

por Abbara, Ali, Eng, Pei Chia, Phylactou, Maria, Clarke, Sophie A., Hunjan, Tia, Roberts, Rachel, Vimalesvaran, Sunitha, Christopoulos, George, Islam, Rumana, Purugganan, Kate, Comninos, Alexander N., Trew, Geoffrey H., Salim, Rehan, Hramyka, Artsiom, Owens, Lisa, Kelsey, Tom, Dhillo, Waljit S.
Publicado 2019

A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial

por Abbara, Ali, Clarke, Sophie, Islam, Rumana, Prague, Julia K, Comninos, Alexander N, Narayanaswamy, Shakunthala, Papadopoulou, Deborah, Roberts, Rachel, Izzi-Engbeaya, Chioma, Ratnasabapathy, Risheka, Nesbitt, Alexander, Vimalesvaran, Sunitha, Salim, Rehan, Lavery, Stuart A, Bloom, Stephen R, Huson, Les, Trew, Geoffrey H, Dhillo, Waljit S
Publicado 2017

Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy

por Abbara, Ali, Jayasena, Channa N., Christopoulos, Georgios, Narayanaswamy, Shakunthala, Izzi-Engbeaya, Chioma, Nijher, Gurjinder M. K., Comninos, Alexander N., Peters, Deborah, Buckley, Adam, Ratnasabapathy, Risheka, Prague, Julia K., Salim, Rehan, Lavery, Stuart A., Bloom, Stephen R., Szigeti, Matyas, Ashby, Deborah A., Trew, Geoffrey H., Dhillo, Waljit S.
Publicado 2015